These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 11268464)
21. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma. Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670 [TBL] [Abstract][Full Text] [Related]
22. Different calculation methods for flow cytometric S-phase fraction: prognostic implications in breast cancer? The Swedish Society of Cancer Study Group. Baldetorp B; Stål O; Ahrens O; Cornelisse C; Corver W; Falkmer U; Fernö M Cytometry; 1998 Dec; 33(4):385-93. PubMed ID: 9845432 [TBL] [Abstract][Full Text] [Related]
23. S-phase fraction and menopausal status as the most important prognostic factors of disease-free survival for node negative patients with breast cancer. A prospective study. Lackowska B; Niezabitowski A; Ryś J; Skołyszewski J; Stelmach A; Gruchała A; Jaszcz-Gruchała A Pol J Pathol; 2003; 54(2):101-10. PubMed ID: 14575418 [TBL] [Abstract][Full Text] [Related]
24. [Multivariate prognostic analysis in gastric carcinoma patients after radical operation]. Zhan YQ; Sun XW; Li W; Chen YB; Xu L; Guan YX; Li YF; Xu DZ Ai Zheng; 2005 May; 24(5):596-9. PubMed ID: 15890105 [TBL] [Abstract][Full Text] [Related]
25. Results of immunochemo-surgery for gastric carcinoma. Kim JP; Yu HJ; Lee JH Hepatogastroenterology; 2001; 48(41):1227-30. PubMed ID: 11677936 [TBL] [Abstract][Full Text] [Related]
26. [Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent S-1-based neoadjuvant/adjuvant chemotherapy]. Sakurai Y; Kamoshida S; Furuta S; Sunagawa R; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y Gan To Kagaku Ryoho; 2008 Jul; 35(7):1147-55. PubMed ID: 18633253 [TBL] [Abstract][Full Text] [Related]
27. Stratification of the biologic aggressiveness of non-small cell lung cancer using DNA flow cytometry and immunohistochemistry for the retinoblastoma protein. Otsuka H; Funai S; Tanaka A; Hara S; Shiozaki H Lung Cancer; 2004 Sep; 45(3):307-16. PubMed ID: 15301871 [TBL] [Abstract][Full Text] [Related]
28. Role of surgery in the patients with stage I and II primary gastric lymphoma. Takahashi I; Maehara Y; Koga T; Sumiyoshi Y; Oshiro T; Baba H; Kohnoe S; Okamura T; Uike N; Matsusaka T; Kume K; Sugimachi K Hepatogastroenterology; 2003; 50(51):877-82. PubMed ID: 12828109 [TBL] [Abstract][Full Text] [Related]
29. Simultaneous detection of apoptosis and proliferation in colorectal carcinoma by multiparameter flow cytometry allows separation of high and low-turnover tumors with distinct clinical outcome. Rupa JD; de Bruïne AP; Gerbers AJ; Leers MP; Nap M; Kessels AG; Schutte B; Arends JW Cancer; 2003 May; 97(10):2404-11. PubMed ID: 12733138 [TBL] [Abstract][Full Text] [Related]
30. Flow cytometric analysis of DNA ploidy and S-phase fraction in primary localized myxofibrosarcoma: correlations with clinicopathological factors, Skp2 expression, and patient survival. Huang HY; Huang WW; Wu JM; Huang CK; Wang JW; Eng HL; Lin CN; Chou SC; Yu SC; Fang FM; Lee JC; Li CF Ann Surg Oncol; 2008 Aug; 15(8):2239-49. PubMed ID: 18516647 [TBL] [Abstract][Full Text] [Related]
31. DNA ploidy and S-phase fraction as prognostic factors in surgically resected gastric carcinoma: a 7-year prospective study. Nesi G; Bruno L; Saieva C; Caldini A; Girardi LR; Zanna I; Rapi S; Bechi P; Cortesini C; Palli D Anticancer Res; 2007; 27(6C):4435-41. PubMed ID: 18214057 [TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of DNA ploidy and proliferative indices in patients with nasopharyngeal carcinoma. Ma J; Nicholas ; Terry HA; Lin SX; Patel N; Mai HG; Hong MH; Lu TX; Cui NJ; Min HQ Ai Zheng; 2002 Jun; 21(6):644-50. PubMed ID: 12452067 [TBL] [Abstract][Full Text] [Related]
33. Clinicopathological characteristics and outcome indicators of stage II gastric cancer according to the Japanese classification of gastric cancer. Ojima H; Araki K; Kato T; Okamura K; Manda R; Hirayama I; Hosouchi Y; Nishida Y; Kuwano H Anticancer Res; 2006; 26(2B):1385-90. PubMed ID: 16619548 [TBL] [Abstract][Full Text] [Related]
34. Prognostic value of DNA flow cytometry in stomach cancer: a 5-year prospective study. Lee KH; Lee JS; Lee JH; Kim SW; Suh C; Kim WK; Kim SH; Min YI; Kim BS; Park KC; Lee MS; Sun HS Br J Cancer; 1999 Apr; 79(11-12):1727-35. PubMed ID: 10206284 [TBL] [Abstract][Full Text] [Related]
35. S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study. Chassevent A; Jourdan ML; Romain S; Descotes F; Colonna M; Martin PM; Bolla M; Spyratos F Clin Cancer Res; 2001 Apr; 7(4):909-17. PubMed ID: 11309341 [TBL] [Abstract][Full Text] [Related]
36. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion]. Słojewski M Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306 [TBL] [Abstract][Full Text] [Related]
37. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR. Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345 [TBL] [Abstract][Full Text] [Related]
38. Significant prognostic factors in patients with early gastric cancer. Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H Int Surg; 2000; 85(4):286-90. PubMed ID: 11589593 [TBL] [Abstract][Full Text] [Related]
39. S-phase fraction as an independent prognostic factor of long-term overall survival in patients with early-stage or locally advanced invasive breast carcinoma. Vielh P; Carton M; Padoy E; de Rycke Y; Klijanienko J; El-Naggar AK; Asselain B Cancer; 2005 Dec; 105(6):476-82. PubMed ID: 16116603 [TBL] [Abstract][Full Text] [Related]
40. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study. Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]